Lysogene

Lysogene is an SME in Neuilly Sur Seine, France that has taken part in 3 EU-funded projects since 2015, receiving €176k in EU funding.

EU funding received€176k
EU projects3
As coordinator0
Running now0
First EU project2015
Latest project2021
CountryFrance
EU registration (PIC)952415259
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Lysogene's own share of each project, not the project's full budget.

  • Horizon 2020€176k · 3 projects

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • SCREEN4CAREPartner

    Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • ARDATPartner

    Accelerating Research & Development for Advanced Therapies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €176ktheir share
  • ADAPT-SMARTPartner

    Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • drug safety
  • ecosystems
  • gene therapy
  • genomes
  • immunology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime